For example, cancer cell-derived EVs carrying HSP90-alpha promote the secretion of IL-6 and IL-8 by monocytes and neutrophils, resulting in CD8+ T cell suppression and reduced efficacy of anti-PD-1/PD-L1 treatment (44). Here, CD8A is linked to cancer.